Tequin, one of the brand names for the pharmaceutical product Gatifloxacin, was introduced to the U.S. market by Bristol-Myers Squibb in 1999. The drug, an antibiotic, was prescribed primarily for the treatment of respiratory tract infections.
In 2006, a report in the New England Journal of Medicine alleged that Tequin had been found to put users at an elevated risk for dysglycemia, a blood sugar metabolism disorder that may manifest as either hyperglycemia (high blood sugar) or hypoglycemia (low blood sugar). Initially, Bristol-Myers Squibb notified health care providers that product warnings would be enhanced. However, the company subsequently opted to terminate the manufacture of Tequin. The product is now available only as treatment for eye conditions, in the form of an eye drop.
If you experienced side effects after being prescribed Tequin, GetLegal has the tools and resources to help you find skilled legal representation to protect your rights. Visit our attorney directory, look for your geographic location and find the best lawyer for your situation.
Defective Drugs & Medical Devices Topics
Divorce and Taxes
If you are facing a divorce, you know that there are plenty of difficult, even painful questi…Read More 07 Dec 2018, Friday
Legalizing Recreational Marijuana: A New State Revolution?
Election night 2018 brought about several changes in the legal landscape, but probably none s…Read More 06 Dec 2018, Thursday
The State(s) of Medicaid Expansion
In 2012, the Patient Protection and Affordable Care Act (“ACA”) made some sweeping chang…Read More 05 Dec 2018, Wednesday